Abstract:2‐Arachidonoyl‐glycerol (2‐AG) is an endocannabinoid with anti‐inflammatory properties. Blocking 2‐AG hydrolysis to enhance CB 2 signaling has proven effective in mouse models of inflammation. However, the expression of 2‐AG lipases has never been thoroughly investigated in human leukocytes. Herein, we investigated the expression of seven 2‐AG hydrolases by human blood leukocytes and alveolar macrophages (AMs) and found the following protein expression pattern: monoacylglycerol (MAG lipase; eosinophils, AMs, monocytes), carboxylesterase (CES1; monocytes, AMs), palmitoyl‐protein thioesterase (PPT1; AMs), α/β‐hydrolase domain (ABHD6; mainly AMs), ABHD12 (all), ABHD16A (all), and LYPLA2 (lysophospholipase 2; monocytes, lymphocytes, AMs). We next found that all leukocytes could hydrolyze 2‐AG and its metabolites derived from cyclooxygenase‐2 (prostaglandin E 2 ‐glycerol [PGE 2 ‐G]) and the 15‐lipoxygenase (15‐hydroxy‐eicosatetraenoyl‐glycerol [15‐HETE‐G]). Neutrophils and eosinophils were consistently better at hydrolyzing 2‐AG and its metabolites than monocytes and lymphocytes. Moreover, the efficacy of leukocytes to hydrolyze 2‐AG and its metabolites was 2‐AG ≥ 15‐HETE‐G >> PGE 2 ‐G for each leukocyte. Using the inhibitors methylarachidonoyl‐fluorophosphonate (MAFP), 4‐nitrophenyl‐4‐(dibenzo[d][1,3]dioxol‐5‐yl(hydroxy)methyl)piperidine‐1‐carboxylate (JZL184), Palmostatin B, 4′‐carbamoylbiphenyl‐4‐yl methyl(3‐(pyridin‐4‐yl)benzyl)carbamate, N‐methyl‐N‐[[3‐(4‐pyridinyl)phenyl]methyl]‐4′‐(aminocarbonyl)[1,1′‐biphenyl]‐4‐yl ester carbamic acid (WWL70), 4′‐[[[methyl[[3‐(4‐pyridinyl)phenyl]methyl]amino]carbonyl]oxy]‐[1,1′‐biphenyl]‐4‐carboxylic acid, ethyl ester (WWL113), tetrahydrolipstatin, and ML349, we could not pinpoint a specific hydrolase responsible for the hydrolysis of 2‐AG, PGE 2 ‐G, and 15‐HETE‐G by these leukocytes. Furthermore, JZL184, a selective MAG lipase inhibitor, blocked the hydrolysis of 2‐AG, PGE 2 ‐G, and 15‐HETE‐G by neutrophils and the hydrolysis of PGE 2 ‐G and 15‐HETE‐G by lymphocytes, two cell types with limited/no MAG lipase. Using an activity‐based protein profiling (ABPP) probe to label hydrolases in leukocytes, we found that they express many MAFP‐sensitive hydrolases and an unknown JZL184‐sensitive hydrolase of ∼52 kDa. Altogether, our results indicate that human leukocytes are experts at hydrolyzing 2‐AG and its metabolites via multiple lipases and probably via a yet‐to‐be characterized 52 kDa hydrolase. Blocking 2‐AG hydrolysis in humans will likely abrogate the ability of human leukocytes to degrade 2‐AG and its metabolites and increase their anti‐inflammatory effects in vivo.

The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors

ABHD6 Selectively Controls Metabotropic-Dependent Increases in 2-AG Production

Brain monoglyceride lipase participating in endocannabinoid inactivation

Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum.

Alpha/Beta-Hydrolase Domain-Containing 6: Signaling and Function in the Central Nervous System

Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6

2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism

Therapeutic potential of targeting α/β-Hydrolase domain-containing 6 (ABHD6)

Augmentation of 2-arachidonoylglycerol signaling in astrocytes maintains synaptic functionality by regulation of miRNA-30b

Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human myeloid leukocytes

Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling

DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses

Human leukocytes differentially express endocannabinoid‐glycerol lipases and hydrolyze 2‐arachidonoyl‐glycerol and its metabolites from the 15‐lipoxygenase and cyclooxygenase pathways

Cyclic AMP‐dependent protein kinase and D1 dopamine receptors regulate diacylglycerol lipase‐α and synaptic 2‐arachidonoyl glycerol signaling

Robust Hydrolysis of Prostaglandin Glycerol Esters by Human Monoacylglycerol Lipase (MAGL)

Overabundant endocannabinoids in neurons are detrimental to cognitive function

Elevated Levels of Arachidonic Acid-Derived Lipids Including Prostaglandins and Endocannabinoids Are Present Throughout ABHD12 Knockout Brains: Novel Insights Into the Neurodegenerative Phenotype

Regulated endosomal trafficking of Diacylglycerol lipase alpha (DAGLα) generates distinct cellular pools; implications for endocannabinoid signaling

Diacylglycerol Lipase-Alpha Regulates Hippocampal-Dependent Learning and Memory Processes in Mice

Polymodal Activation of the Endocannabinoid System in the Extended Amygdala.

Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina